Treatments of actinic cheilitis: a systematic review of the literature.
No large studies defined the best treatment for actinic cheilitis. We conducted a systematic review in order to define the best therapies of actinic cheilitis in terms of clinical response and recurrences. We first identified 444 papers and 49 were finally considered, including 789 patients and 843 treated areas. The following therapies were recorded in order of frequency: laser-therapy, photodynamic therapy (PDT), 3% diclofenac in 2.5% hyaluronic acid, PDT+5% imiquimod, ALA- or MAL- laser, 5% imiquimod, fluorouracil, partial surgery, 0.015% ingenol mebutate, 50% trichloroacetic acid and laser+PDT. Concerning the primary outcome 85.9% of patients underwent complete clinical response and 11.0% had clinical recurrences. Partial surgery and laser therapy showed the highest complete response rates (14/14 [100%] and 244/260 [93.8%], respectively) with low recurrences. Only a limited number of patients were treated with other therapies, with the exception of PDT with 68.9% complete responses and 12.6% of recurrences. Interestingly, when combined with 5% imiquimod efficacy of PDT was significantly enhanced. Heterogeneity across studies. Laser therapy appears as the best option among non-surgical approaches for actinic cheilitis, while PDT showed higher efficacy when sequentially combined with 5% imiquimod. Larger studies are needed to confirm these data.